Onkologie. 2014:8(5):208-211

Radiotherapy for renal-cell carcinoma

Jana Zitterbartová, Petr Burkoň, Ludmila Hynková, Pavel Šlampa
Klinika radiační onkologie LF Masarykovy univerzity a Masarykova onkologického ústavu, Brno

Treatment of renal cell carcinoma with ionizing radiation is currently on the border between the modern concept. Radiotherapy, which

always belonged to the domain of palliative treatment of renal carcinoma, finds new application in the treatment of primary and metastatic

lesions in the form of ablative doses exceeding traditionally reported radioresistance. The use of modern techniques of stereotactic

irradiation offers patients an effective gentle treatment with a high probability of local control and prolonged symptom-free period.

Hand in hand with targeted medical treatment further contributes to the treatment of metastatic disease. Palliative radiotherapy still

forms an integral part of care for symptomatic patients.

Keywords: renal cell carcinoma, stereotactic body radiation therapy, palliative radiotherapy

Published: October 16, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zitterbartová J, Burkoň P, Hynková L, Šlampa P. Radiotherapy for renal-cell carcinoma. Onkologie. 2014;8(5):208-211.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Meerleer GD, Khoo V, Escudier B, et al. Radiotherapy for renal-cell carcinoma. Lancet Oncol. 2014; 15: e170-77. Go to original source... Go to PubMed...
    2. Lutz S, Chow E, Hoskin P. Radiation oncology in palliative care, John Wiley ? Sons, Ltd., Publication, 2013; 190-197. Go to original source...
    3. NCCN Clinical Practice guidelines in oncology. Kidney cancer, version 3.2014.
    4. Polcari R, Gorbonos A, Milner JE, Flanigan RC. The role of cytoreductive nephrectomy in the era of molecular targeted therapy. Int J Urol. 2009 Mar; 16 (3): 227-33. Go to original source... Go to PubMed...
    5. Büchler T. Sekvenční léčba metastatického karcinomu ledviny. Postgraduální medicína 2014; 16 (3): 297-301.
    6. Šlampa P, Zitterbartova J, Krupa P. Léčba metastatického karcinomu ledviny, Farmakon Press spol.s.r.o 2013; 17-21.
    7. Fuks Z, Kolesnick R. Engaging the vascular component of tumor response. Cancer cell 2005; 8: 89-91. Go to original source... Go to PubMed...
    8. Šlampa P, Petera J. a kolektiv. Radiační onkologie, Praha: Galén-Karolinum 2007; 307-14.
    9. Stein M, Kuten A, Halperin J, et al. The value of postoperative irradiation in renal cell cancer, Radiother Oncol 1992; 24: 41-44. Go to original source... Go to PubMed...
    10. Makarewicz R, Zarzycka M, Kulińska G, Windorbska W. The value of postoperative radiotherapy in advanced renal cell cancer. Neoplazma 1998; 45 (6): 380-3.
    11. Quantitative Analyses of Normal Tissue Effects in the Clinic, Int J Radiat Oncol Biol Phys. 2010 Mar 1; 76 (3 Suppl): S1-S160.
    12. Hynková L, Šlampa P a kolektiv. Základy radiační onkologie, Masarykova univerzita 2012; 211-214.
    13. Lippitz B, Lindquist Ch, Paddick I, et al. Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treatment Reviews 2014; 40 (1): 48-59. Go to original source... Go to PubMed...
    14. Svedman C, Karlsson K, Rutkowska E, et al. Stereotacitic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney. Acta Oncol 2008; 47; 1578-83. Go to original source... Go to PubMed...
    15. Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. BJU Int 2012; 110: E737-43. Go to original source... Go to PubMed...
    16. Teh B, Bloch C, Galli-Guevara M, et al. The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed Imaging Interv J 2007; 3: e6. Go to original source... Go to PubMed...
    17. Kao J, Chen CT, Thong CC, et al. Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of prospective clinical trial. Target Oncol. 2014 Jun; 9 (2): 145-53. Go to original source... Go to PubMed...
    18. Wersäll PJ, Blongren H, Lax I, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 2005; 77: 88-95. Go to original source... Go to PubMed...
    19. Ranck MC, Golden DW, Corbin KS, et al. Sereotactic body radiotherapy for treatment of oligometastatic renal cell carcinoma. Am J Clin Oncol 2013; 36: 589-595. Go to original source... Go to PubMed...
    20. SIOP Wilms Tumor 2001/UK Final Version/January 2002.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.